UCLH - University College London Hospitals NHS Foundation Trust

A red heat-health alert has been issued across parts of England until 25 June. This is the highest level of alert and indicates a risk to everyone's health, not just vulnerable groups.

Learn more about how to stay safe in hot weather.

➡️ https://www.nhs.uk/live-well/seasonal-health/heatwave-how-to-cope-in-hot-weather/

A new documentary follows former Channel 4 presenter Jon Snow as he navigates life with and his participation in a key clinical trial run by UCL and UCLH.

Jon is best known for presenting Channel 4 News between 1989 and 2021. He decided to open up about his diagnosis to raise awareness of a condition which is the UK’s biggest killer and affects around a million people in this country.

Jon is seen talking to UCLH consultant, Professor Jonathan Rohrer, who explains that there is currently no cure for dementia, but there are some treatments.

Professor Rohrer said: “We are deeply grateful to Jon for using his powerful storytelling ability to help break down stigma and by bravely sharing his own personal experience."

Learn more about the documentary here: https://buff.ly/MxRyORy

At UCLH, we are extremely proud of our staff and their dedication to delivering the best care for our patients.

If you have been treated or looked after by an exceptional member of staff or a volunteer, we would love you to tell us about it.

Learn more about our Celebrating Excellence Awards: https://buff.ly/VQcLvFX

Congratulations to our UCLH colleagues Dr Urshla “Oosh” Devalia and Professor Sarah Tabrizi who have both been recognised in the King’s Birthday Honours 2026 list.

Dr Devalia has been awarded an OBE in recognition of her contribution to children and young people’s oral health across the UK and Professor Tabrizi has been awarded an CBE for services to people with Huntington's Disease (HD).

UCLH chief executive David Probert said: “Congratulations to Dr Devalia and Professor Tabrizi. It is fantastic to see your hard work, passion, and expertise recognised in this way, and we are very grateful to your contributions to our patients and services at UCLH.”

Read more: https://buff.ly/MWumHK5

A new, life-extending drug for ovarian cancer which was trialled at UCLH is now available on the NHS.

It is the first new addition to NHS treatment for ovarian cancer in over 20 years, following an announcement by NHS England.

Dr Rowan Miller (pictured), who ran the clinical trials at UCLH in research supported by the National Institute for Health and Care Research Biomedical Research Centre at UCLH, said: "Finally, there's a drug that's available, that improves survival for this group of patients and in addition, the patients get on with the treatment well and find it easier to manage than standard chemotherapy.”

Find out more: https://buff.ly/02kel6U

“It’s like night and day,” says Katie Tinkler of her life before and after CAR T cell therapy. She suffered from lupus for years before she went into remission, and credits her participation in the CARLYSLE trial with changing her life. “I can participate in life now,” she says.

The pioneering clinical trial led by UCLH and UCL is showing early promise for people with severe lupus who have exhausted existing treatment options.

Early results from the ongoing Phase I CARLYSLE trial have been encouraging. As of November 2025, nine adults with severe, treatment-resistant lupus had received the treatment. All had highly active disease despite multiple previous therapies, and most had lupus nephritis, a serious form of the disease that affects the kidneys.

Researchers found that five of the first six patients treated at the lower dose achieved remission according to standard lupus criteria, with improvements emerging within months of treatment.

Patients also experienced rapid reductions in disease activity, alongside improvements in important laboratory markers associated with lupus.

Katie hopes her experience offers encouragement to others living with severe autoimmune disease. Meanwhile, UCLH and partners are continuing work on severl clinical trials testing CAR T cell therapy in autoimmune diseases in the hope of finding new ways of improving patients’ lives.

Read more: https://buff.ly/y9CPuAZ

COVID-19 can be very dangerous for older adults.

We have walk-in availability, Monday to Friday, at our vaccine clinic for the COVID-19 spring booster. If you are eligible, or you know someone who may be vulnerable, please come forward for your vaccine before 30 June.

View clinic details and opening times: buff.ly/JX9SmxD

Pleased to support staff networks including Proud making UCLH - University College London Hospitals NHS Foundation Trust a more inclusive place to work.

COVID-19 can be very dangerous for older adults.

We have walk-in availability, Monday to Friday, at our vaccine clinic for the COVID-19 spring booster. If you are eligible, or you know someone who may be vulnerable, please come forward for your vaccine before 30 June.

View clinic details and opening times: buff.ly/KL6V64h